2016 Section 5 Green Book

Stachler

67. Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with aller- gen. J Allergy Clin Immunol . 1992;89:611–618. 68. Piotrowski W, Foreman JC. Some effects of calcitonin gene-related peptide in human skin and on histamine release. Br J Dermatol . 1986;114:37–46. 69. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev . 2006;86:279– 367. 70. Canning BJ. Reflex regulation of airway smooth mus- cle tone. J Appl Physiol . 2006;101:971–85. 71. National Heart, Lung, and Blood Institute. Guide- lines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert Panel Report. J Allergy Clin Immunol. 1991;88:425–534. 72. van den Toorn LM, Overbeek SE, de Jongste JC, et al. Airway inflammation is present during clinical remis- sion of atopic asthma. Am J Respir Crit Care Med 2001;164:2107–13.

61. Dunnill MS, Massarella GR, Anderson JA. A com- parison of the quantitative anatomy of the bronchi in normal subjects in status asthmaticus in chronic bron- chitis, and in emphysema. Thorax . 1969;24:176–179. 62. Kay AB. Asthma and inflammation. J Allergy Clin Im- munol . 1991;87:893–910. 63. Fontanari P, Burnet H, Zatarra-Hartmann MC, et al. Changes in airway resistance induced by nasal inhala- tion of cold dry, dry, or moist air in normal individu- als. J Appl Physiol . 1996;81:1739–1743. 64. Sarin S, Undem B, Sanico A, et al. The role of the nervous system in rhinitis. J Allergy Clin Immunol . 2006;118:999–1014. 65. Braunstahl GJ. The unified immune system: res- piratory tract-nasobronchial interaction mechanism in allergic airway disease. J Allergy Clin Immunol . 2005;115:142–148. 66. Beeh KM, Beier J, Kornmann O, et al. A single nasal al- lergen challenge increases induced sputum inflamma- tory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy . 2003;33:475–482.

54. Eliashar R, Levi-Schaffer F. The role of the eosinophil in nasal diseases. Curr Opin Otolaryngol Head Neck Surg . 2005;13:171–175. 55. Rosenberg HF, Phipps S, Foster PS. Eosinophil traf- ficking in allergy and asthma. J Allergy Clin Immunol . 2007;119:1303–1310. 56. Shturman-Ellstein R, Zeballos RJ, Buckley JM, et al. The beneficial effect of nasal breathing on exercise- induced bronchoconstriction. Am Rev Respir Dis . 1978;118:65–73. 57. Hamilos D. Chronic sinusitis. J Allergy Clin Immunol . 2000;106:213–227. 58. Bachert C, Vignola AM, Gevaert P, et al. Allergic rhinitis, rhinosinusitis, and asthma: one airway dis- ease. Immunol Allergy Clin North Am . 2004;24:19– 43. 59. Alam R, Stafford RA, Forsythe P, et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol . 1993;150:3442–3448. 60. Dunnill MS. The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol . 1960;13:27–33.

International Forum of Allergy & Rhinology, Vol. 5, No. S1, September 2015

213